Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
105 participants
OBSERVATIONAL
2013-07-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inflammatory knee osteoarthritis
One group of patients with inflammatory condition in physical evaluation. We will make a blood analyse and arthrocentesis when synovial fluid were found in ultrasound examination. Ultrasound of affected knee and carotid artery will be performed.
Blood analyse, arthrocentesis, ultrasound examination
Non-inflammatory knee osteoarthritis
Patients with no inflammatory condition in physical examination. We will make a blood analyse and arthrocentesis when synovial fluid were found in ultrasound examination. Ultrasound of affected knee and carotid artery will be performed.
Blood analyse, arthrocentesis, ultrasound examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood analyse, arthrocentesis, ultrasound examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Any other rheumatologic condition.
50 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parc TaulĂ Hospital Universitari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joan Calvet Fontova
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
jordi Gratacos, MD Ph
Role: STUDY_DIRECTOR
Hospital Parc Tauli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Parc Tauli Sabadell
Sabadell, Barcelona, Spain
Hospital Parc Tauli
Sabadell, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joan Calvet, Dr
Role: primary
Joan Calvet, Dr
Role: primary
Cristobal Orellana, Dr
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Joan01
Identifier Type: -
Identifier Source: org_study_id